Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920733 · ClinicalTrials.gov registry record · NA
Healthy Lifetime - Phase 2
A NA study of Aging Well, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05920733: Recruiting NA study of Aging Well, sponsored by University of Michigan.
NCT05920733 is a NA study of Aging Well that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 120 participants, above the 55-participant average among 7 other Aging Well trials with a reported enrollment target (118% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920733, a NA study of Aging Well, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
HealthyLifetime (HL) is a person-centered program that enables older adults to maximize health and optimize functioning - the necessary requisite to successfully remaining independent in their preferred home setting as long as possible, i.e., to age in place.
Primary Outcome
Participants perception of their health on a scale of 1= Excellent to 5 = Poor
Conditions Studied
Interventions
- BEHAVIORAL Nurse-led health coaching
Study Locations (1)
Michigan
- University of Michigan School of Nursing - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT05920733 shows while recruiting
NCT05920733 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 55-participant average among 7 other Aging Well trials with a reported enrollment target (118% higher).
The record links to 1 condition, with Aging Well appearing as the primary indexed condition, and to 1 intervention - of which Nurse-led health coaching is the first listed.
NCT05920733 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05920733 about?
NCT05920733 is a clinical study titled "Healthy Lifetime - Phase 2". HealthyLifetime (HL) is a person-centered program that enables older adults to maximize health and optimize functioning - the necessary requisite to successfully remaining independent in their preferred home setting as long as possible, i.e., to age in place.
What is the current status of trial NCT05920733?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-07-05. Estimated completion is 2026-10-01.
What conditions does trial NCT05920733 study?
This clinical trial studies the following conditions: Aging Well.
What interventions are being tested in trial NCT05920733?
The interventions under investigation include: Nurse-led health coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT05920733?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05920733 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging Well
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Emotional Well-being and Measures of Healthy Aging
RECRUITING · NA
-
Transcranial Pulse Stimulation of the Brain
RECRUITING · NA
-
Comparing Sports Bra Design in Full Busted Women
COMPLETED · NA
-
In-home Yoga for Seniors
COMPLETED · NA
-
Aquatic Exercise for Cognition and Mobility in Older Adults
COMPLETED · NA
-
Rejuvant™ Safety and Biomarker Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI